SCHEMBL26528202

SCHEMBL26528202

Cc1ccc2c(c1)-n1c(nc3ccccc31)C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.42
MAPT P10636 5/20 0.41
RAB9A P51151 5/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41
PKM P14618 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
TP53 P04637 1/20 0.39
NQO2 P16083 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
NPC1 O15118 3/20 0.38
LMNA P02545 1/20 0.38
ACHE P22303 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
GRM2 Q14416 1/20 0.37
PIK3CD O00329 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26528200 0.82 NQO2 (0.39) TSHRMAPTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL25592448 0.81 TSHR (0.45) TSHRRAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL24120864 0.76 TSHR (0.49) TSHRRAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL15631604 0.71 TSHR (0.71) TSHRMAPTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL19721186 0.69 TSHR (0.50) TSHRMAPTRAB9ASMN1; SMN2KDM4E
SCHEMBL20041714 0.69 TSHR (0.58) TSHRMAPTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL18624190 0.68 ALKBH5 (0.38) MAPTRAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL17570830 0.67 TSHR (0.55) TSHRMAPTRAB9AALDH1A1POLB
SCHEMBL19486136 0.67 TSHR (0.48) TSHRMAPTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL20041626 0.67 SMN1; SMN2 (0.37) TSHRRAB9ASMN1; SMN2KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11793073-B2 Host materials for electroluminescent devices UNIVERSAL DISPLAY CORPORATION (US) 2023-10-17 US disclosed
US-11744152-B2 Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications UDC IRELAND LIMITED (IE) 2023-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11793073-B2 Host materials for electroluminescent devices MCM6, MCM2, MCM4 TSHR 4613/4885MAPT 3557/4885RAB9A 927/4885
US-11744152-B2 Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications PAICS, EIF4A1, ECI1 TSHR 3749/4885MAPT 2317/4885RAB9A 1588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.